Publications

Export 250 results:
Sort by: [ Author (Asc)] Title Type Year
Filters: First Letter Of Last Name is M  [Clear All Filters]
A B C D E F G H I J K L [M] N O P Q R S T U V W X Y Z   [Show ALL]
M
MacColl G, Bouloux P, Quinton R. Kallmann syndrome: adhesion, afferents, and anosmia. Neuron. 2002;34:675-8. Abstract
MacColl GS, Novo FJ, Marshall NJ, Waters M, Goldspink G, Bouloux PM. Optimisation of growth hormone production by muscle cells using plasmid DNA. The Journal of endocrinology. 2000;165:329-36. Abstract
MacColl G, Bunn C, Goldspink G, Bouloux P, Górecki DC. Intramuscular plasmid DNA injection can accelerate autoimmune responses. Gene therapy. 2001;8:1354-6. Abstract
MacColl GS, Goldspink G, Bouloux PM. Using skeletal muscle as an artificial endocrine tissue. The Journal of endocrinology. 1999;162:1-9. Abstract
MacDonald P, MacKenzie S, Ramage LE, Seckl JR, Brown RW. Corticosteroid regulation of amiloride-sensitive sodium-channel subunit mRNA expression in mouse kidney. The Journal of endocrinology. 2000;165:25-37. Abstract
MacDonald MR, Connelly DT, Hawkins NM, Steedman T, Payne J, Shaw M, et al. Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart. 2011;97(9):740-7. Abstract
Macdonald CA, Sboros V, Gomatam J, Pye SD, Moran CM, Norman McDicken W. A numerical investigation of the resonance of gas-filled microbubbles: resonance dependence on acoustic pressure amplitude. Ultrasonics. 2004;43(2):113-22. Abstract
Macfarlane DP, Forbes S, Walker BR. Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome. The Journal of endocrinology. 2008;197:189-204. Abstract
Macfarlane DP, Zou X, Andrew R, Morton NM, Livingstone DE, Aucott RL, et al. Metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency: implications for the pathogenesis of steatohepatitis. Am J Physiol Endocrinol Metab. 2011;300(2):E402-9. Abstract
Macfarlane DP, Zou X, Andrew R, Morton NM, Livingstone DE, Aucott RL, et al. Metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency; implications for the pathogenesis of steatohepatitis. Am J Physiol Endocrinol Metab. 2010. Abstract
Macintyre IM, Dhaun N, Lilitkarntakul P, Melville V, Goddard J, Webb DJ. Greater functional ETB receptor antagonism with bosentan than sitaxsentan in healthy men. Hypertension. 2010;55(6):1406-11. Abstract
Macintyre IM, Dhaun N, Goddard J, Webb DJ. Ambrisentan and its role in the management of pulmonary arterial hypertension. Drugs of today (Barcelona, Spain : 1998). 2008;44:875-85. Abstract
MacKenzie SM, Clark CJ, Ingram MC, Lai M, Seckl J, Gomez-Sanchez CE, et al. Corticosteroid production by fetal rat hippocampal neurons. Endocrine research. 2000;26:531-5. Abstract
Mackinnon A, Sethi T. [D-Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism. Methods Mol Med. 2003;74:299-307.
Mackinnon AC, Tufail-Hanif U, Wheatley M, Rossi AG, Haslett C, Seckl M, et al. Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies. Br J Pharmacol. 2009;156(1):36-47. Abstract
Mackinnon AC, Buckley A, Chilvers ER, Rossi AG, Haslett C, Sethi T. Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents. Journal of immunology (Baltimore, Md. : 1950). 2002;169:6394-400. Abstract
Mackinnon AC, Spedding M, Brown CM. Sodium modulation of 3H-agonist and 3H-antagonist binding to alpha 2-adrenoceptor subtypes. Br J Pharmacol. 1993;109(2):371-8. Abstract
Mackinnon AC, Waters C, Rahman I, Harani N, Rintoul R, Haslett C, et al. [Arg(6), D-Trp(7,9), N(me)Phe(8)]-substance P (6-11) (antagonist G) induces AP-1 transcription and sensitizes cells to chemotherapy. Br J Cancer. 2000;83(7):941-8. Abstract
Mackinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, Leffler H, et al. Regulation of alternative macrophage activation by galectin-3. J Immunol. 2008;180(4):2650-8. Abstract
Mackinnon AC, Kilpatrick AT, Kenny BA, Spedding M, Brown CM. [3H]-RS-15385-197, a selective and high affinity radioligand for alpha 2-adrenoceptors: implications for receptor classification. Br J Pharmacol. 1992;106(4):1011-8. Abstract
Mackinnon AC, Armstrong RA, Waters CM, Cummings J, Smyth JF, Haslett C, et al. [Arg6,D-Trp7,9,NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism. Br J Cancer. 1999;80(7):1026-34. Abstract
Mackinnon AC, Buckley A, Chilvers ER, Rossi AG, Haslett C, Sethi T. Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents. J Immunol. 2002;169(11):6394-400. Abstract
Mackinnon AC, Kopatz J, Sethi T. The molecular and cellular biology of lung cancer: identifying novel therapeutic strategies. Br Med Bull. 2010;95:47-61. Abstract
Mackinnon AC, Kopatz J, Sethi T. The molecular and cellular biology of lung cancer: identifying novel therapeutic strategies. Br Med Bull. 2010;95:47-61. Abstract
Mackinnon AC, Brown CM, Spedding M, Kilpatrick AT. [3H]-idazoxan binds with high affinity to two sites on hamster adipocytes: an alpha 2-adrenoceptor and a non-adrenoceptor site. Br J Pharmacol. 1989;98(4):1143-50. Abstract